Genetics

370

Therapeutic Options for ADH1 and Hypoparathyroidism
MinuteCE®
Therapeutic Options for ADH1 and Hypoparathyroidism
- Michael A. Levine, MD, FAAP, MACE, FACP
  Peer
- B. Michelle Schweiger, DO, MPH
  Peer
1.00 program credits
CASR and ADH1: Integrating Biology and Genetic Screening
MinuteCE®
CASR and ADH1: Integrating Biology and Genetic Screening
- Michael A. Levine, MD, FAAP, MACE, FACP
  Peer
- B. Michelle Schweiger, DO, MPH
  Peer
1.00 program credits
MinuteCE®
The Future of ADH1 - Looking at Emergent Treatments
- Michael A. Levine, MD, FAAP, MACE, FACP
  Peer
- B. Michelle Schweiger, DO, MPH
  Peer
1.00 credits 4 episodes
Emerging Therapeutics in ADH1: Progress in Precision Medicine
MinuteCE®
Emerging Therapeutics in ADH1: Progress in Precision Medicine
- Michael A. Levine, MD, FAAP, MACE, FACP
  Peer
- B. Michelle Schweiger, DO, MPH
  Peer
1.00 program credits
Increasing ADH1 Awareness: A Hidden Cause of Hypoparathyroidism
MinuteCE®
Increasing ADH1 Awareness: A Hidden Cause of Hypoparathyroidism
- Michael A. Levine, MD, FAAP, MACE, FACP
  Peer
- B. Michelle Schweiger, DO, MPH
  Peer
1.00 program credits
Case Management Strategies for Patients with ADPKD – Part 2
CME/CE
Case Management Strategies for Patients with ADPKD – Part 2
- Frederic Rahbari-Oskoui, MD, MSc
  Peer